Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NH Investment & Securities is one of the largest securities firms in South Korea, providing a wide range of financial services including wealth management, investment banking, brokerage, and merchant banking through an extensive domestic branch network and overseas subsidiaries[2][4]. The company is active as an investor in various sectors—including healthcare and biotech—but does not itself develop drugs or medical technologies[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NH Investment & Securities.